US Weekly IPO and SPAC Monitor : Just One IPO Biotech Nuvectis Pharma

Following Thanksgiving week we have just one IPO due. Phase 1-ready biotech Nuvectis Pharma ($NVCT) plans to raise $30 million at a $160 million market cap.  Be aware there is still a chance that a handful of SPACs will price during the week. Phase 1-ready biotech Nuvectis Pharma ($NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently … Continue reading “US Weekly IPO and SPAC Monitor : Just One IPO Biotech Nuvectis Pharma”